alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                      19,944,880
<SECURITIES>                                10,408,671
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            30,894,661
<PP&E>                                       5,685,898
<DEPRECIATION>                               3,205,272
<TOTAL-ASSETS>                              33,444,171
<CURRENT-LIABILITIES>                        2,245,986
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  4,972,406
<COMMON>                                       131,809
<OTHER-SE>                                  25,645,757
<TOTAL-LIABILITY-AND-EQUITY>                33,444,171
<SALES>                                              0
<TOTAL-REVENUES>                               919,666
<CGS>                                                0
<TOTAL-COSTS>                               10,148,545
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (9,228,879)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (9,228,879)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (9,228,879)
<EPS-PRIMARY>                                   (0.72)
<EPS-DILUTED>                                   (0.72)
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM THE FINANCIAL
STATEMENTS OF MEADOWCRAFT, INC. FOR THE QUARTER ENDED MAY 2, 1998 AND IS
QUALIFED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUL-31-1998
<PERIOD-END>                               MAY-02-1998
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                   78,313
<ALLOWANCES>                                         0
<INVENTORY>                                     33,300
<CURRENT-ASSETS>                               115,398
<PP&E>                                          84,131
<DEPRECIATION>                                 (22,110)
<TOTAL-ASSETS>                                 178,115
<CURRENT-LIABILITIES>                           84,445
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           197
<OTHER-SE>                                      44,615
<TOTAL-LIABILITY-AND-EQUITY>                   178,115
<SALES>                                         81,840
<TOTAL-REVENUES>                                81,840
<CGS>                                           52,849
<TOTAL-COSTS>                                   52,849
<OTHER-EXPENSES>                                 5,210
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,606
<INCOME-PRETAX>                                 22,175
<INCOME-TAX>                                     3,550
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    18,625
<EPS-PRIMARY>                                      .95
<EPS-DILUTED>                                      .94
        

</TABLE>
FILED U.S. COURT OF AP P EALS E LEVEN T HC IRC UIT SEPT 3, 2008 THOMAS K. KAH

N CLERK [ DO NO T P UB L I S H] I N THE UN I TE D STATE S C OU RT OF APPE ALS F O R T H E E L E V E N T H C IR C U IT

________________________ N o. 08- 10719 N on -A rgum entC al endar

________________________ D . C. D o c k e tN o . 0 7 - 0 0 3 2 2 - CR- T- 2 3 - M SS U N I T E D S T A T E S O F A M E R I C A , P la in tif f - A p p e lle e , v ersu s R O B E R T O M . F E R R O , D e f e n d an t- A p p e llan t.

________________________ A pp ea l fr om the U ni t ed S t at es D i stri ctC ou rt f orthe M i ddl e D i s tr i c tof F l or i da

_________________________ ( S e p t e m b e r 3, 2008) B efo re B L A C K , B A R K E T T an dP R Y O R , C i rcu i tJu d g es. P E R C U R I A M: R yan T ho m as T ruskoski , appo i nt ed coun se l for R ob ert o M . F erro, has2

m ov ed t o w i thd raw fr om further r epre se nt at i on of the appel l antand fi l ed a bri ef pur s ua ntt o A nde r s v. C a l i f orni a , 386 U . S . 738, 87 S . C t . 1396, 18 L . E d. 2d 493 (1 9 6 7 ). O u r in d ep en d en t rev iew o f th e e n ti re re co rd re v ea ls th at co u n se l’ s a s s e s s m e ntof

the r e l a t i ve m e r i tof

the appe a l i s c orr e c t . B e c aus e i nde pe nde nt ex am in atio n o f th e e n ti re re co rd re v ea ls n o ar g u ab le issu es o f m er it , co u n se l’ s m o t i o n t o w i th d raw i s G R A N TED , and K i l go re ’ s c on vi ct i on and sent ence ar e A FFI R M ED .
<PAGE>


                                                                EXHIBIT 32(a)

 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350
    AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, John C. Hunter III, Chief Executive Officer of Solutia Inc. (the
"Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

     (1)  the Quarterly Report on Form 10-Q of the Company for the quarterly
          period ended March 31, 2004 (the "Report") fully complies with the
          requirements of Section 13(a) or 15(d) of the Securities Exchange
          Act of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of
          operations of the Company.

Dated: April 30, 2004

                                                /s/ JOHN C. HUNTER III
                                                -----------------------
                                                John C. Hunter III
                                                Chief Executive Officer



A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Solutia Inc.
and will be retained by Solutia Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.
EXHIBIT 99.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of United Energy Corp. (the "Company") on
Form 10-K for the year ending March 31, 2003 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Sanford M. Kimmel,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350,
as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that: (1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and (2) The information contained in the Report
fairly presents, in all material respects, the financial condition and result of
operations of the Company.

Dated:   June 30, 2003              By: /s/ Sanford M. Kimmel
                                       ----------------------
                                       Sanford M. Kimmel
                                       Chief Financial Officer

This certification accompanies this Report on Form 10-K pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required
by such Act, be deemed filed by the Company for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5732 Introduced in House (IH)]

111th CONGRESS
  2d Session
                                H. R. 5732

 To amend title XVIII of the Social Security Act to permit coverage of 
  certain covered part D drugs for uses that are determined to be for 
  medically accepted indications based upon clinical evidence in peer 
                      reviewed medical literature.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 14, 2010

 Ms. Kilroy (for herself, Mr. Thornberry, and Mr. Burgess) introduced 
 the following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on Ways and Means, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL

 
 To amend title XVIII of the Social Security Act to permit coverage of 
  certain covered part D drugs for uses that are determined to be for 
  medically accepted indications based upon clinical evidence in peer 
                      reviewed medical literature.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Part D Off-Label Prescription Parity 
Act''.

SEC. 2. REVISED DEFINITION OF MEDICALLY ACCEPTED INDICATION FOR 
              MEDICARE COVERED PART D DRUGS.

    (a) In General.--Section 1860D-2(e)(4) of the Social Security Act 
(42 U.S.C. 1395w-102(e)(4)) is amended by adding at the end the 
following new subparagraph:
                    ``(D) Clarification.--Notwithstanding subparagraph 
                (A)(ii), none of the provisions of this subsection 
                shall prevent a PDP sponsor offering a prescription 
                drug plan or an MA organization offering an MA-PD plan 
                from determining (whether through a determination, 
                reconsideration of such a determination, or an appeal 
                of such a determination under section 1852(g) or 
                subsection (g) or (h) of section 1860D-4, as 
                applicable) that a use of a covered part D drug is for 
                a medically accepted indication for purposes of 
                coverage of such drug under such plan if such 
                determination is based upon guidance provided by the 
                Secretary for determining accepted uses of covered part 
                D drugs and on supportive clinical evidence in peer 
                reviewed medical literature.''.
    (b) Effective Date.--The amendment made by this section shall apply 
to plan years beginning on or after January 1, 2011.
                                 <all>
```
#### Jan C. Yazowski-Collier et al., Appellants, v Angela P. Longo, Constituting the Oneida County Board of Elections, et al., Respondents.

Present — Callahan, J. P., Boomer, Green and Lawton, JJ. (Order entered Oct. 30, 1986.)
(August 24, 1987)

#### In the Matter of John D. Gleason, Appellant, v Salvatore J. Longo et al., Constituting the Board of Elections of the County of Schenectady, et al., Respondents.

Per Curiam.

Appeal from a judgment of the Supreme Court (Lynch, J.), entered August 19, 1987 in Schenectady County, which, *inter alia,*denied petitioner’s application, in a proceeding pursuant to Election Law § 16-102, to declare invalid the designating petition naming respondent Joyce F. Easton as the Democratic candidate for the office of Member of Town Council, Town of Duanesburg, in the September 15, 1987 primary election.

Respondent Joyce F. Easton (hereinafter respondent) filed an eight-page designating petition containing 68 signatures naming her as the Democratic candidate for the office of Member of Town Council, Town of Duanesburg, in the upcoming primary election. Thirty-six valid signatures are needed to gain a place on the ballot in the Democratic primary in the Town of Duanesburg. Petitioner unsuccessfully challenged respondent’s designating petition both before the Schenectady County Board of Elections and in this proceeding before Supreme Court. On this appeal by petitioner, we reverse Supreme Court’s judgment, grant petitioner’s application and invalidate respondent’s designating petition.

Paul H. Lambert, Sr., is the subscribing witness for the first four pages of respondent’s designating petition. In addition, Lambert and his wife acted as signatories to page 7 of the petition. In each instance where their signature appears in the petition, the residence given is ”74 R.D. 2 Delanson”. However, testimony taken before Supreme Court from Lambert clearly indicates that the Lamberts’ correct residence is "101 R.D. 1, Mariaville Road, Delanson”. Since the correct residence address is statutorily required from both those who sign and witness a designating petition (Election Law §§ 6-130, *2906-132 [1], [2]), the Lamberts’ error invalidates their individual signatures on page 7 of the petition in addition to the 30 signatures contained on the first four pages witnessed by Lambert *(see, Matter of Liepshutz v Palmateer,*112 AD2d 1101, 1103, *affd,*65 NY2d 965).

Similarly invalid is the signature of Arthur W. Cole on page 6 of the designating petition. His testimony before Supreme Court indicates that his residence is on Wells Road, rather than on Levey Road as stated opposite his signature on the petition.

Since our rulings based on improper residence addresses invalidate 33 of the 68 signatures, leaving respondent with less than the 36 valid signatures needed to sustain her designating petition, we do not reach the remaining issues raised on this appeal.

Judgment reversed, on the law and the facts, without costs, petition granted and designating petition declared invalid. Mahoney, P. J., Kane, Casey, Weiss and Levine, JJ., concur.
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markm an Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra

, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

_________________________________________ Clerk September 4, 2012

t0827 

# Order

September 4, 2012

144534 & (17)(18)

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 144534

COA: 306714

Kent CC: 09

- 002014

- FC

DARRYL EDWARD CHANEY

, Defendant

- Appellant.

_________________________________________/

On order of the Court, the application for leave to appeal the December 16 , 2011

order of the Court of Appeals is considered, and it is DENIED, because the defendant has

failed to meet the burden of establishing entitlement to relief under MCR 6.508(D). The

motions to remand and to appoint counsel are DENIED.
Exhibit 32

                            CERTIFICATION PURSUANT TO
                                 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection  with the 10k-SB/A of American  Utilicraft  Corporation  (the
"Company"),  the undersigned  officers hereby certify that the Company's amended
annual report on Form 10-KSB/A for the year that ended on December 31, 2001 (the
"Report"),  as filed with the  Securities  and Exchange  Commission  on the date
hereof,

     a)   fully complies with the  requirements of section 13(a) or 15(d) of the
          Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o (d)); and

     b)   that information  contained in the periodic report fairly presents, in
          all  material  respects,   the  financial  condition  and  results  of
          operations of the issuer

     This certificate is provided solely pursuant to 18 U.S.C.  Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not
be  deemed  to be a part  of the  Report  or  "filed"  for  any  other  purposes
whatsoever.

     IN WITNESS WHEREOF, the Company has caused this certificate to be signed by
it Chief Financial Officer and its Principal Accounting Officer this 28th day of
October, 2004.


/s/ John J. Dupont                                   /s/ M. Karen Shoemaker
-------------------------------------               ----------------------------
John J. Dupont                                      M. Karen Shoemaker
President and Chief Executive Officer               Principal Accounting Officer
[Federal Register Volume 86, Number 178 (Friday, September 17, 2021)]
[Notices]
[Pages 51908-51909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20107]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 51909]]

amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Allergy, Immunology, and Transplantation 
Research Committee; Allergy, Immunology, and Transplantation 
Research Committee.
    Date: October 14-15, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities/Room 3G31B, National Institutes of Health, NIAID, 5601 
Fishers Lane, Room 3G31, Bethesda, MD 20892-9834, (240) 669-5060, 
<a href="/cdn-cgi/l/email-protection#81ebe0ece4f2aff2eff8e5e4f3c1efe8e9afe6eef7"><span class="__cf_email__" data-cfemail="462c272b23356835283f22233406282f2e68212930">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 13, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20107 Filed 9-16-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>

                                                                    EXHIBIT 32.3

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Pyramid Breweries Inc. (the
"Company") on Form 10-Q for the period ending March 31, 2005 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Jason
W. Rees, Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.

/s/ JASON W. REES
------------------------

Jason W. Rees
Chief Accounting Officer
May 16, 2005
# C_2021459EN.01004301.xml

| 12.11.2021 | EN | Official Journal of the European Union | C 459/43 |
| --- | --- | --- | --- |

12.11.2021

EN

Official Journal of the European Union

C 459/43

---

EUROPEAN UNION AGENCY FOR FUNDAMENTAL RIGHTS

Publication of the final accounts for the financial year 2020

(2021/C 459/43)

The complete version of the final accounts may be found at the following address:

https://fra.europa.eu/en/about-fra/finance-and-budget/financial-documents

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
unaudited condensed consolidated balance sheet as of September 30, 1999 and the
unaudited condensed consolidated statement of operations for the nine months
ended September 30, 1999, and is qualified in its entirety by reference to such
financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                          23,368
<SECURITIES>                                   812,196
<RECEIVABLES>                                  187,803
<ALLOWANCES>                                    10,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,077,351
<PP&E>                                         181,526
<DEPRECIATION>                                  91,643
<TOTAL-ASSETS>                               1,633,852
<CURRENT-LIABILITIES>                        3,204,690
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           828
<OTHER-SE>                                 (1,507,838)
<TOTAL-LIABILITY-AND-EQUITY>                 1,633,852
<SALES>                                        944,640
<TOTAL-REVENUES>                               944,640
<CGS>                                          216,750
<TOTAL-COSTS>                                1,101,141
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              63,929
<INCOME-PRETAX>                              (220,429)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (220,429)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                582,921
<CHANGES>                                            0
<NET-INCOME>                                   362,492
<EPS-BASIC>                                     0.05
<EPS-DILUTED>                                     0.05


</TABLE>